Chiome Bioscience Inc.

4583.T · JPX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-¥1,021-¥1,215-¥1,238-¥1,466
Dep. & Amort.¥1¥1¥1¥3
Deferred Tax¥0¥0¥0¥0
Stock-Based Comp.¥0¥0¥0¥0
Change in WC¥51¥143¥28¥174
Other Non-Cash-¥32¥2¥18¥159
Operating Cash Flow-¥1,001-¥1,069-¥1,191-¥1,131
Investing Activities
PP&E Inv.¥0¥0¥0¥0
Net Acquisitions¥0¥0¥0¥0
Inv. Purchases¥0¥0¥0¥0
Inv. Sales/Matur.¥0¥0¥0¥0
Other Inv. Act.¥0¥0¥0-¥35
Investing Cash Flow¥0¥0¥0-¥35
Financing Activities
Debt Repay.-¥10¥107¥1¥3
Stock Issued¥1,750¥555¥1,126¥254
Stock Repurch.¥0¥0¥0¥0
Dividends Paid¥0¥0¥0¥0
Other Fin. Act.-¥2¥6-¥0¥15
Financing Cash Flow¥1,738¥667¥1,127¥271
Forex Effect¥0¥0¥0¥0
Net Chg. in Cash¥738-¥402-¥64-¥895
Supplemental Information
Beg. Cash¥1,326¥1,727¥1,791¥2,686
End Cash¥2,063¥1,326¥1,727¥1,791
Free Cash Flow-¥1,001-¥1,069-¥1,191-¥1,131
Chiome Bioscience Inc. (4583.T) Financial Statements & Key Stats | AlphaPilot